# Zentalis Pharmaceuticals, Inc.: Form 8-K, filed Aug 14, 2026

- Company: [Zentalis Pharmaceuticals, Inc.](/companies/zntl.md) (CIK 1725160)
- Form: 8-K
- Filed: 2026-08-14
- Accepted by EDGAR: Aug 14, 2026, 16:09 ET
- Period: 2026-08-13
- Accession: 0001628280-26-057112
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1725160/000162828026057112/zntl-20260813.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1725160/000162828026057112/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1725160/000162828026057112/zntl-20260813.htm

Filed Aug 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-057112. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.